The initial public offering price range for Molbio Diagnostics has been established, with a target of raising ₹940 crore. Subscription will begin on August 10, featuring a combination of fresh share issuance and offer for sale. Leading this endeavor are Kotak Mahindra Capital and IIFL Capital Services, assisted by Jefferies India and Motilal Oswal as book-running lead managers.